Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival

OBJECTIVES: The advent of the tyrosine kinase inhibitors has markedly changed the prognostic outlook for patients with Ph(+) and/or BCR-ABL1(+) chronic myeloid leukemia (CML). This study was designed to assess the overall survival (OS) of Nigerian patients with CML receiving imatinib therapy and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyekunle, Anthony A., Durosinmi, Muheez A., Bolarinwa, Ramoni A., Owojuyigbe, Temilola, Salawu, Lateef, Akinola, Norah O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915783/
https://www.ncbi.nlm.nih.gov/pubmed/27375361
http://dx.doi.org/10.4137/CMBD.S31562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915783/
https://www.ncbi.nlm.nih.gov/pubmed/27375361
http://dx.doi.org/10.4137/CMBD.S31562

Ejemplares similares